drugset / Trial / NCT00315107

Estrogen Treatment in Acromegalic Women

NCT00315107 ↗

Phase 2 Unknown 30 enrolled University of Montreal Novartis · collab
RandomizedParallel-groupDouble-blind

Summary

Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.

Timeline

Start
2006-05
Primary completion
—
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Alesse Unknown — —

Indications